Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Oxford Specialist Integrated Haematological Malignancy Diagnostic Service

Haematological malignancies are a diverse group of cancers which affect the blood, bone marrow and the lymphatic systems.

Their clinical presentation, therapy options, prognosis and survival rates vary significantly, so it is vital that diagnosis, prognosis determination and disease monitoring is accurate and timely.

The Oxford Specialist Integrated Haematological Malignancy Diagnostic Service (SIHMDS) was set up in 2011 to provide a comprehensive assessment of patients with diagnosed or suspected haematological malignancies.

The service incorporates all the pathology specialisms associated with haematological malignancy diagnosis including:

  • morphology
  • histology including immunohistochemistry
  • immunophenotyping
  • cytogenetics
  • FISH
  • molecular studies.

The different sections of the laboratory are unified in a process that covers all investigational pathways, has a single central specimen reception and issues a single integrated report.

Contact us

Oxford Molecular Haematology Laboratory
Level 4, John Radcliffe Hospital
Oxford OX3 9DU

Monday to Friday 9.00am - 5.00pm
Tel: 01865 572769